148777-84-8 Usage
General Description
3-Nitro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine is a chemical compound that is a tetrahydropyrazolopyrimidine derivative. It is synthesized by the nitration of 4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine. 3-Nitro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyriMidine is known for its potential pharmaceutical properties, particularly its potential use as a diuretic and antihypertensive agent. Additionally, it has been studied for its potential use in the treatment of cardiovascular diseases. Research has also demonstrated its potential as an antitubercular agent. However, further studies are needed to fully elucidate its biological activities and potential therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 148777-84-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,8,7,7 and 7 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 148777-84:
(8*1)+(7*4)+(6*8)+(5*7)+(4*7)+(3*7)+(2*8)+(1*4)=188
188 % 10 = 8
So 148777-84-8 is a valid CAS Registry Number.
148777-84-8Relevant articles and documents
CEPHEM COMPOUNDS AND USE AS ANTIMICROBIAL AGENTS
-
Page/Page column 47-48, (2008/06/13)
The present invention provides a compound of the formula [I]: wherein R1 is lower alkyl, etc. and R2 is hydrogen, etc., or R1 and R2 are bonded together to form lower alkylene; R3 is a group represented by wherein R6 and R7 are independently optionally pr
Hair dye containing aminopyrazole derivatives as well as pyrazole derivatives
-
, (2008/06/13)
The composition for oxidative dyeing of hair contains at least one coupler and 0.010 to 3.0 percent by weight of at least one developer selected from the group consisting of aminopyrazole derivatives of the formula (I): STR1 wherein R is selected from the group consisting of hydrogen and alkyl groups having one to four carbon atoms; n=2 or 3; and physiologically tolerated, water-soluble salts thereof. The developer and coupler substances are present in the composition in a total amount of from 0.1 to 5.0 percent. New pyrazole derivative compounds are also part of the invention.